Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump

Celon Pharma's experimental semaglutide product Reduzek, a generic alternative to Novo ​Nordisk's Wegovy and Ozempic, matched ‌the blockbuster weight-loss drugs in an early-stage bioequivalence study,...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。